Literature DB >> 15281521

Pain and sensory dysfunction 6 to 12 months after inguinal herniotomy.

Trine Mikkelsen1, Mads U Werner, Birgit Lassen, Henrik Kehlet.   

Abstract

Inguinal hernia repair is associated with a 5%-30% incidence of chronic pain, but the pathogenesis remains unknown. We therefore evaluated pain and sensory dysfunction by quantitative sensory testing 6-12 mo after open hemiorrhaphy. Before sensory testing, all patients (n = 72) completed a short-form McGill Pain Questionnaire and a functional impairment questionnaire. Sensory dysfunction in the incisional area was evaluated by quantification of thermal and mechanical thresholds, by mechanical pain responses (von Frey/pressure algometry), and by areas of pinprick hypoesthesia and tactile allodynia. The incidence of chronic pain was 28% (20 of 72). Quantitative sensory testing and pressure algometry did not demonstrate differences between the pain and nonpain groups, except for a small but significant increase in pain response to von Frey hair and brush stimulation in the pain group. Hypoesthesia, or tactile allodynia, in the incisional area was observed in 51% (37 of 72) of the patients, but the incidence did not differ significantly between the pain group and the nonpain group (14 of 20 versus 23 of 52; P > 0.3). We concluded that cutaneous hypoesthesia, or tactile allodynia, is common after inguinal hemiotomy but has a low specificity for chronic postherniotomy pain. Factors other than nerve damage may be involved in the development of chronic posthemiotomy pain.

Entities:  

Mesh:

Year:  2004        PMID: 15281521     DOI: 10.1213/01.ane.0000115147.14626.c5

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  25 in total

Review 1.  Costs and quality of life after endoscopic repair of inguinal hernia vs open tension-free repair: a review.

Authors:  M Gholghesaei; H R Langeveld; R Veldkamp; H J Bonjer
Journal:  Surg Endosc       Date:  2005-05-14       Impact factor: 4.584

Review 2.  Perioperative Hyperalgesia and Associated Clinical Factors.

Authors:  Obaid S Malik; Alan D Kaye; Richard D Urman
Journal:  Curr Pain Headache Rep       Date:  2017-01

3.  The assessment of quality of life in a trial on lightweight mesh fixation with fibrin sealant in transabdominal preperitoneal hernia repair.

Authors:  R H Fortelny; R Schwab; K S Glaser; K U Puchner; C May; F König; H Redl; A H Petter-Puchner
Journal:  Hernia       Date:  2008-04-08       Impact factor: 4.739

4.  Analysis of the SAGES Outcomes Initiative groin hernia database.

Authors:  V Velanovich; P Shadduck; L Khaitan; J Morton; G Maupin; L W Traverso
Journal:  Surg Endosc       Date:  2005-12-06       Impact factor: 4.584

Review 5.  Surgically induced neuropathic pain: understanding the perioperative process.

Authors:  David Borsook; Barry D Kussman; Edward George; Lino R Becerra; Dennis W Burke
Journal:  Ann Surg       Date:  2013-03       Impact factor: 12.969

Review 6.  Management of persistent postsurgical inguinal pain.

Authors:  Mads U Werner
Journal:  Langenbecks Arch Surg       Date:  2014-05-23       Impact factor: 3.445

7.  Quantitative validation of sensory mapping in persistent postherniorrhaphy inguinal pain patients undergoing triple neurectomy.

Authors:  M F Bjurström; R Álvarez; A L Nicol; R Olmstead; P K Amid; D C Chen
Journal:  Hernia       Date:  2017-01-13       Impact factor: 4.739

Review 8.  Analgesic therapy for major spine surgery.

Authors:  Varun Puvanesarajah; Jason A Liauw; Sheng-fu Lo; Ioan A Lina; Timothy F Witham; Allan Gottschalk
Journal:  Neurosurg Rev       Date:  2015-02-14       Impact factor: 3.042

9.  Preventing Chronic Pain following Acute Pain: Risk Factors, Preventive Strategies, and their Efficacy.

Authors:  Kai McGreevy; Michael M Bottros; Srinivasa N Raja
Journal:  Eur J Pain Suppl       Date:  2011-11-11

10.  Evaluating postherniorrhaphy groin pain: Visual Analogue or Verbal Rating Scale?

Authors:  M J A Loos; S Houterman; M R M Scheltinga; R M H Roumen
Journal:  Hernia       Date:  2007-11-15       Impact factor: 4.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.